These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Acute dystonia]. Van Harten PN Ned Tijdschr Geneeskd; 1997 Jul; 141(30):1471-4. PubMed ID: 9542880 [TBL] [Abstract][Full Text] [Related]
25. Proportion of life lived with dystonia inversely correlates with response to pallidal deep brain stimulation in both primary and secondary childhood dystonia. Lumsden DE; Kaminska M; Gimeno H; Tustin K; Baker L; Perides S; Ashkan K; Selway R; Lin JP Dev Med Child Neurol; 2013 Jun; 55(6):567-74. PubMed ID: 23452222 [TBL] [Abstract][Full Text] [Related]
27. Effects of rubral microinjections of muscimol and bicuculline in a genetic animal model of paroxysmal dystonia. Hamann M; Richter A Brain Res; 2004 May; 1008(1):126-30. PubMed ID: 15081391 [TBL] [Abstract][Full Text] [Related]
29. Tardive dystonia. Kang UJ; Burke RE; Fahn S Adv Neurol; 1988; 50():415-29. PubMed ID: 3400500 [TBL] [Abstract][Full Text] [Related]
30. Beyond the Burke-Fahn-Marsden Dystonia Rating Scale: deep brain stimulation in childhood secondary dystonia. Gimeno H; Tustin K; Selway R; Lin JP Eur J Paediatr Neurol; 2012 Sep; 16(5):501-8. PubMed ID: 22258088 [TBL] [Abstract][Full Text] [Related]
31. Parkinson's goal: ease symptoms, slow progression. Johns Hopkins Med Lett Health After 50; 2006 Jun; 18(4):4-5. PubMed ID: 16795901 [No Abstract] [Full Text] [Related]
32. Systemic therapy of dystonia. Fahn S Can J Neurol Sci; 1987 Aug; 14(3 Suppl):528-32. PubMed ID: 3315156 [TBL] [Abstract][Full Text] [Related]
33. [A case of amoxapine-induced tardive dystonia successfully treated with a low dose anti-cholinergic agent]. Hayashi Y; Ohyagi Y; Inoue I; Arakawa K; Taniwaki T; Nakagawa M; Kuwabara Y; Yamada T; Kira J Rinsho Shinkeigaku; 2000 Apr; 40(4):367-71. PubMed ID: 10967655 [TBL] [Abstract][Full Text] [Related]
34. Drug treatment for vertigo and dizziness. Darlington CL; Smith PF N Z Med J; 1998 Sep; 111(1073):332-4. PubMed ID: 9785546 [No Abstract] [Full Text] [Related]
35. Medical therapy and botulinum toxin in dystonia. Jankovic J Adv Neurol; 1998; 78():169-83. PubMed ID: 9750914 [No Abstract] [Full Text] [Related]
38. Treatment of dystonia in Parkinson's disease. Tsui JK Adv Neurol; 2003; 91():361-4. PubMed ID: 12442694 [No Abstract] [Full Text] [Related]
39. Dopamine agonists and antagonists in the treatment of idiopathic dystonia. Lang AE Adv Neurol; 1988; 50():561-70. PubMed ID: 3041761 [No Abstract] [Full Text] [Related]